The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world (RW) treatment (tx) patterns and outcomes of 3,455 previously untreated mantle cell lymphoma (MCL) patients (pts) in U.S. routine clinical practice.
 
Peter Martin
Consulting or Advisory Role - Bayer; BeiGene; Celgene; Cellectar; I-Mab; Janssen; Karyopharm Therapeutics; Kite, a Gilead company; Kite/Gilead; MorphoSys; Regeneron; Sandoz; TeneoBio; Verastem
Research Funding - Karyopharm Therapeutics (Inst)
Travel, Accommodations, Expenses - Janssen
 
Michael Wang
Stock and Other Ownership Interests - More Health
Honoraria - AstraZeneca; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries; Onclive; oncology business review; Peerview; Pharmacyclics; Targeted Oncology
Consulting or Advisory Role - AstraZeneca; AxImmune; Bioinvent; Celgene; Guidepoint Global; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; More Health; Noble Insights; Pharmacyclics/Janssen; Pulse Biosciences
Research Funding - Acerta Pharma; Amgen; AstraZeneca; BeiGene; Bioinvent; Celgene; Janssen Research & Development; Juno Therapeutics; Kite, a Gilead company; Loxo; Novartis; Oncternal Therapeutics; Pharmacyclics; VelosBio; Verastem
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Dava Oncology; Janssen Research & Development; OM Pharmaceutical Industries
 
Anita Kumar
Stock and Other Ownership Interests - Bridgebio
Consulting or Advisory Role - AstraZeneca/MedImmune; Celgene; Kite, a Gilead company
Research Funding - Abbvie/Genentech; Adaptive Biotechnologies; AstraZeneca/MedImmune; Celgene; Pharmacyclics; Seagen; Seagen
 
Keqin Qi
Employment - Janssen
 
Katherine Daly
Employment - Janssen
 
Lori Parisi
Employment - Janssen
 
Angeline Zhu
Employment - Janssen
 
Gilles A. Salles
Honoraria - Abbvie; Celgene; Gilead Sciences; Janssen; MorphoSys; Novartis; Roche/Genentech
Consulting or Advisory Role - Alimera Sciences; BeiGene; Bristol-Myers Squibb; Celgene; Debiopharm Group; Epizyme; Genmab; Genmab; Gilead Sciences; Incyte; Janssen; Miltenyi Biotec; morphosys; Novartis; Roche/Genentech; Velosbio